Simultaneous radiotherapy and radioimmunotherapy of malignant gliomas with anti-EGFR antibody labelled with iodine 125. Preliminary results

Nuclear Medicine Review

Volumn 5, Issue 1, 2002, Pages 29-33

  Wygoda, Zbigniew ^a   Tarnawski, Rafał ^a   Brady, Luther ^a   Stȩplewski, Zenon ^a   Bazowski, Piotr ^a   Wojtacha, Maciej ^a   Stȩpień, Tomasz ^a   Kula, Dorota ^a   Składowski, Krzysztof ^a   Kokocińska, Danuta ^a   Wygoda, Andrzej ^a   Pawlaczek, Agnieszka ^a   Etmańska, Aleksandra ^a   Larysz, Dawid ^a   Jarza̧b, Barbara ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Anaplastic astrocytoma; Epidermal growth factor receptor; Glioblastoma; Iodine 125; Monoclonal antibody 425; Radioimmunotherapy

Indexed keywords

DEXAMETHASONE; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; IODINE 125; MANNITOL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 425; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; ISOTOPE LABELING; MALE; NEUROSURGERY; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0036302596     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
2. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOG) clinical trials
3. 1H spectroscopy in vivo for evaluation of tumor bed metabolism in glioma patients treated by postoperative radiotherapy
4. 131l monoclonal antibody: Feasibility, pharmacokinetics and dosimetry
5. Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase
6. A pilot study of the treatment of patients with recurrent malignant gliomas with intratumoral yttrium-90 radioimmunoconjugates
7. 131l-labelled anti-tenascin monoclonal antibody BC-2
8. Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial
9. Epidermal growth factor 425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of high-grade astrocytomas
10. Domain-specificity and antagonistic properties of new monoclonal antibody to the EGF-receptor
11. The receptor for EGF and its ligands: Expression, prognostic value and target for therapy in cancer
12. Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors
13. Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situ T-cell activation and therapeutic efficacy
14. Targeting retrovirus to cancer cells expressing a mutant EGF receptor by insertion of a single chain antibody variable domain in the envelope glycoprotein receptor binding lobe
15. Role of target antigen in bispecific-antibody-mediated killing of human glioblastoma cells: A pre-clinical study
16. 125l-labeled monoclonal antibody 425 against cancer cells containing epidermal factor receptor
17. 3HTdR
18. Iodine-125 cytotoxicity: Implications for therapy and estimations of radiation risk
19. 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas
20. Role of TE 1H-MR spectroscopy in monitoring of post-operation irradiated patients
21. Gene expression profiling contributes to human glioma classification
22. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients
23. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-genes
24. cDNA expression profiling reveals molecular targets and biochemical pathways underlying a rational strategy for treating invasive malignant human glioma cells
25. Reverse transcriptase polymerase chain reaction as a reliable method to detect epidermal growth factor receptor exon 2-7 gene deletion in human glioblastomas
26. Epidermal growth factor receptor internalization rate is regulated by negative charges near the SH2 binding site Tyr992
27. Expression of cancer testis genes in human brain tumors